DEXTRAN SULFATE MICROPARTICLES ENCAPSULATING ISONIAZID AND/OR RIFABUTIN AS CARRIERS FOR PULMONARY TUBERCULOSIS THERAPY

被引：0
|
作者：
Musacchio, Flavia
Grenha, Ana
机构：
[1] Univ Algarve, Fac Sci & Technol, Ctr Biomed Res CBMR, P-8005139 Faro, Portugal
[2] Univ Algarve, Ctr Marine Sci CCMar, P-8005139 Faro, Portugal
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2017年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
64
引用
收藏
页码：A20 / A21
页数：2
相关论文
共 50 条
  • [21] Factors Associated with Absence of Active Pulmonary Tuberculosis in HIV Patients with Latent Tuberculosis, Beyond Isoniazid Preventive Therapy
    Yuniati, Shinta Karina
    Kusmiati, Tutik
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2024, 13 (03) : 293 - 298
  • [22] THE INTERMITTENT USE OF STREPTOMYCYLIDENE ISONICOTINYL HYDRAZINE SULFATE IN THE THERAPY OF PULMONARY TUBERCULOSIS
    PAYNE, HM
    QUARLES, C
    MCKNIGHT, HV
    ELLISON, O
    HARDEN, KA
    SYPHAX, GB
    TURNER, OD
    AMERICAN REVIEW OF TUBERCULOSIS, 1954, 70 (04): : 701 - 713
  • [23] COMPARATIVE EFFICACY OF THE CONCURRENT USE OF PYRAZINAMIDE AND ISONIAZID WITH THAT OF OTHER FORMS OF THERAPY IN THE TREATMENT OF PULMONARY TUBERCULOSIS
    SCHWARTZ, JA
    DISEASES OF THE CHEST, 1957, 32 (04): : 455 - 459
  • [24] In Vitro Evaluation of Inhalable Isoniazid-Loaded Surfactant Liposomes as an Adjunct Therapy in Pulmonary Tuberculosis
    Chimote, G.
    Banerjee, R.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2010, 94B (01) : 1 - 10
  • [25] THE COURSE OF PULMONARY TUBERCULOSIS DURING LONG-TERM SINGLE-DRUG (ISONIAZID) THERAPY
    DEUSCHLE, K
    ORMOND, L
    ELMENDORF, D
    MUSCHENHEIM, C
    MCDERMOTT, W
    AMERICAN REVIEW OF TUBERCULOSIS, 1954, 70 (02): : 228 - +
  • [26] Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month
    Singh, Amit K.
    Verma, Rahul K.
    Mukker, Jatinder Kaur
    Yadav, Awadh B.
    Muttil, Pavan
    Sharma, Rolee
    Mohan, Mradul
    Agrawal, Atul K.
    Gupta, Anuradha
    Dwivedi, Anil K.
    Gupta, Pushpa
    Gupta, Umesh D.
    Mani, Uthirappan
    Chaudhari, Bhushan P.
    Murthy, Ramesh C.
    Sharma, Sharad
    Bhadauria, Smrati
    Singh, Sarika
    Rath, Srikanta Kumar
    Misra, Amit
    TUBERCULOSIS, 2021, 128
  • [27] Childhood Tuberculosis and Isoniazid Preventive Therapy Among Household Contacts of Sputum Positive Pulmonary Tuberculosis Patients: A Descriptive Observational Study
    Shanbag, Namita
    Haseeb, Mohammad
    Engade, Madhuri
    Siddiqui, Mohd Saeed
    Badaam, Khaled M.
    Nelanuthala, Madhurasree
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [28] Inhalable Fucoidan Microparticles Combining Two Antitubercular Drugs with Potential Application in Pulmonary Tuberculosis Therapy
    Cunha, Ludmylla
    Rodrigues, Susana
    Rosa da Costa, Ana M.
    Leonor Faleiro, M.
    Buttini, Francesca
    Grenha, Ana
    POLYMERS, 2018, 10 (06)
  • [29] THE SEROGRAM IN PULMONARY TUBERCULOSIS ELECTROPHORETIC SERUM PROTEIN FRACTION CHANGES DURING ISONIAZID THERAPY - A PRELIMINARY REPORT
    SAIFER, A
    ORESKES, I
    VOLK, BW
    AMERICAN REVIEW OF TUBERCULOSIS, 1954, 70 (02): : 334 - 343
  • [30] FURTHER EXPERIENCES WITH THE CLINICAL USE OF STREPTOMYCYLIDENE ISONICOTINYL HYDRAZINE SULFATE IN THE THERAPY OF PULMONARY TUBERCULOSIS
    PAYNE, HM
    HARDEN, KA
    MCKNIGHT, HV
    SYPHAX, GB
    TURNER, OD
    JASON, RS
    DISEASES OF THE CHEST, 1956, 30 (04): : 385 - 403
12345